TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Tataa Biocenter AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,196
|
4,701
|
3,300 |
| Financial expenses |
0
|
1
|
32 |
| Earnings before taxes |
-4,344
|
-5,440
|
-5,437 |
| EBITDA |
-3,915
|
-4,914
|
-4,897 |
| Total assets |
3,150
|
3,947
|
3,984 |
| Current assets |
2,091
|
2,414
|
2,037 |
| Current liabilities |
1,448
|
1,288
|
2,390 |
| Equity capital |
1,702
|
2,659
|
1,594 |
| - share capital |
12
|
13
|
12 |
| Employees (average) |
41
|
46
|
47 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
54.0%
|
67.4%
|
40.0% |
| Turnover per employee |
78
|
102
|
70 |
| Profit as a percentage of turnover |
-135.9%
|
-115.7%
|
-164.8% |
| Return on assets (ROA) |
-137.9%
|
-137.8%
|
-135.7% |
| Current ratio |
144.4%
|
187.4%
|
85.2% |
| Return on equity (ROE) |
-255.2%
|
-204.6%
|
-341.1% |
| Change turnover |
-1,345
|
1,391
|
-5,166 |
| Change turnover % |
-30%
|
42%
|
-61% |
| Chg. No. of employees |
-5
|
-1
|
6 |
| Chg. No. of employees % |
-11%
|
-2%
|
15% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.